Provided by Tiger Fintech (Singapore) Pte. Ltd.

Treace Medical Concepts, Inc.

6.99
-0.4200-5.67%
Post-market: 6.990.00000.00%17:18 EDT
Volume:355.54K
Turnover:2.50M
Market Cap:437.54M
PE:-7.77
High:7.41
Open:7.24
Low:6.82
Close:7.41
Loading ...

BRIEF-Treace Announces Upcoming Board Chair Transition

Reuters
·
07 Apr

Treace Medical Concepts Names John Treace as Chairman

MT Newswires Live
·
07 Apr

Treace Medical Concepts Inc - Appoints John T. Treace as Chairman of the Board

THOMSON REUTERS
·
07 Apr

Treace Announces Upcoming Board Chair Transition

THOMSON REUTERS
·
07 Apr

Treace Medical Concepts Inc - James T. Treace to Retire From Board on May 20, 2025

THOMSON REUTERS
·
07 Apr

Press Release: Treace Announces Upcoming Board Chair Transition

Dow Jones
·
07 Apr

Treace Medical Concepts Studies of Procedures to Treat Mid-Foot Deformities Show Positive Results

MT Newswires Live
·
29 Mar

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 Acfas Annual Scientific Conference

THOMSON REUTERS
·
29 Mar

Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference

GlobeNewswire
·
29 Mar

Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference

GlobeNewswire
·
26 Mar

Treace Medical Concepts Is Maintained at Hold by Truist Securities

Dow Jones
·
13 Mar

Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)

TIPRANKS
·
13 Mar

Truist Adjusts Price Target on Treace Medical Concepts to $9.50 From $10, Maintains Hold Rating

MT Newswires Live
·
13 Mar

John Treace Spends US$524k On Treace Medical Concepts Stock

Simply Wall St.
·
09 Mar

CEO Makes Bold Move with Major Stock Purchase in Treace Medical Concepts

TIPRANKS
·
05 Mar

Stock Track | Treace Medical Concepts Plummets 5.21% as Analysts Maintain Neutral Ratings

Stock Track
·
04 Mar

Treace Medical Concepts Is Maintained at Hold by Truist Securities

Dow Jones
·
04 Mar

UBS Adjusts Treace Medical Concepts Price Target to $10 From $7.90, Maintains Neutral Rating

MT Newswires Live
·
04 Mar

Truist Financial Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)

TIPRANKS
·
03 Mar

Treace Medical Concepts Inc : Truist Securities Raises Target Price to $10 From $8.4

THOMSON REUTERS
·
03 Mar